BioSenic : Annual Report 2023 EN - MarketScreener

FINANCIAL REPORT 2023


p.2







Table of contents



...

Related Keywords

China ,Belgium ,United States ,Zaventem ,Region Flamande ,Paris ,France General ,France ,Walloon Brabant ,Waals Gewest ,Mont Saint Guibert ,Walloon Region ,Nivelles ,Chinese ,French ,Belgian ,Anne Cauvet ,Entreprises Instituut ,Carole Nicco ,Rodrigo Abels ,Rue Granbonpr ,Arthur Decellas ,Dominique Rongvaux ,Lieven Huysse ,Yannick Allanore ,Christophe Guignabert ,Moniteur Belge ,Mina Ottaviani ,European Investment Bank ,Belgian Code On Companies ,Biosenic United States Inc ,National Bank ,Link Health Pharma ,Phebra Pty Ltd ,Biosenic Group ,Correctives Actions ,Executive Committee ,Reverse Merger ,Authorized Capital ,Plans Issued ,Outstanding Warrant Plans ,Financial Position ,Comprehensive Income ,Cash Flow ,Annual Report ,Belgian Code ,Elsinore Building ,Belgian Institut ,Industry Information ,Les Echos ,Aavailable Information ,Belgian Official Gazette ,Investor Relations ,Euronext Brussels ,Belgian Royal Decree ,Investor Relations Rue Granbonpr ,Bone Therapeutics ,Systemic Lupus Erythematosus ,Chronic Graft ,Host Disease ,Bone Therapeutic ,Scientific Director ,Medical Director ,Chief Scientific ,Blink Health ,Chief Medical ,Dominique Rongvaux Ga ,Marine Thomas ,Res Ther ,